Is NutriBand Inc. (NTRBW) Halal?
Shariah Screening — 5 Standards
Based on financial data from January 2025
| Standard | Debt Ratio | Cash Ratio | Receivables | Income | Status |
|---|---|---|---|---|---|
| AAOIFI | N/A | N/A | N/A | N/A | ? INSUFFICIENT DATA |
| DJIM | N/A | N/A | N/A | N/A | ? INSUFFICIENT DATA |
| MSCI | 2.5% / 33% | 57.7% / 33% | 1.0% / 33% | 8.96% / 5% | ✗ NOT HALAL |
| S&P | N/A | N/A | N/A | N/A | ? INSUFFICIENT DATA |
| FTSE | 2.5% / 33% | 57.7% / 33% | 1.0% / 50% | 8.96% / 5% | ✗ NOT HALAL |
Financial Highlights
Profitability
| Gross Margin | 33.5% | |
| Operating Margin | -1121.3% | |
| Net Margin | 0.0% | |
| Return on Equity (ROE) | -136.1% | |
| Return on Assets (ROA) | -55.2% |
Cash Flow & Balance Sheet
| Operating Cash Flow | -$5M |
| Free Cash Flow | -$5M |
| Total Debt | $186,349 |
| Debt-to-Equity | 3.4 |
| Current Ratio | 7.5 |
| Total Assets | $7M |
Price & Trading
| Last Close | $1.13 |
| 50-Day MA | $1.44 |
| 200-Day MA | $1.75 |
| Avg Volume | 1K |
| Beta | 1.9 |
|
52-Week Range
$0.80
| |
About NutriBand Inc. (NTRBW)
Nutriband Inc. develops a portfolio of transdermal pharmaceutical products in the United States. The company's lead product in development is AVERSA fentanyl, an abuse deterrent fentanyl transdermal system that provides clinicians and patients with an extended-release transdermal fentanyl product for use in managing chronic pain requiring around the clock opioid therapy. It also develops AVERSA buprenorphine and AVERSA methylphenidate, and other transdermal pharmaceutical products. The company has commercial development and clinical supply agreement with Kindeva Drug Delivery. The company was incorporated in 2016 and is headquartered in Orlando, Florida.
Related Halal Stocks in
Frequently Asked Questions
Is NutriBand Inc. (NTRBW) halal to invest in?
Based on our screening using AAOIFI Standard 21 (the strictest methodology), NutriBand Inc. is Not Halal. The company fails one or more screening criteria. We screen against all 5 major standards: AAOIFI, DJIM, MSCI, S&P, and FTSE.
What is NutriBand Inc.'s debt ratio?
NutriBand Inc.'s debt ratio is not available under the AAOIFI standard (which uses market capitalization as the denominator). The AAOIFI threshold is 30%. Under MSCI and FTSE (which use total assets as the denominator), the debt ratio is 2.5%.
What are NutriBand Inc.'s key financial metrics?
NutriBand Inc. has a market capitalization of N/A, and revenue of $2M. Return on equity stands at -136.1%.
How often is the screening data updated?
Our screening data is updated regularly using the latest available financial statements and market data. Stock prices and market caps are refreshed frequently, while financial statements are updated quarterly when companies report earnings.
Disclaimer: HalalStockGuide.com provides Shariah compliance screening for educational and informational purposes only. This is not a fatwa, financial advice, or a recommendation to buy or sell any security. Screening results are based on publicly available financial data and established methodologies. Always consult a qualified Islamic scholar and a licensed financial advisor before making investment decisions.